Dar Zavain 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2024-04-01+1,467→ 89,056 total
Footnotes (2)
- [F1]Shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
- [F2]Includes a total of 32,373 shares received pursuant to a pro-rata distribution from Lux Ventures, of which the Reporting Person was a limited partner. The acquisition of such shares was exempt pursuant to Rule 16a-9 and was inadvertently excluded from the total amount of shares held on the Reporting Person's Forms 4 since July 12, 2023.